Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.39 |
| ▸ | FDPS | P14324 | 9/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15111129 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL28318572 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL27507939 | 0.88 | TSHR (0.50) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL10956083 | 0.88 | — | — | |
| SCHEMBL6001216 | 0.88 | TSHR (0.50) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL5259843 | 0.83 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL27593546 | 0.83 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL11237840 | 0.83 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL27548205 | 0.82 | TSHR (0.41) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL30124746 | 0.78 | TSHR (0.44) | TSHRTHRBGGPS1FDPSCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2618824-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | Kareus Therapeutics SA (FR) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012040177-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | KAREUS THERAPEUTICS, SA (CH) | 2012-03-29 | — | — | WO | disclosed |